These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8759892)

  • 21. Syndecan-1/CD138 expression in normal myeloid, acute lymphoblastic and myeloblastic leukemia cells.
    Seftalioglu A; Karakus S
    Acta Histochem; 2003; 105(3):213-21. PubMed ID: 13677614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.
    Kraj M; Pogłód R; Kopeć-Szlezak J; Sokołowska U; Woźniak J; Kruk B
    Leuk Lymphoma; 2004 Nov; 45(11):2281-9. PubMed ID: 15512818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of clonogenic multiple myeloma cells.
    Matsui W; Huff CA; Wang Q; Malehorn MT; Barber J; Tanhehco Y; Smith BD; Civin CI; Jones RJ
    Blood; 2004 Mar; 103(6):2332-6. PubMed ID: 14630803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large scale and clinical grade purification of syndecan-1+ malignant plasma cells.
    Sun RX; Lu ZY; Wijdenes J; Brochier J; Hertog C; Rossi JF; Klein B
    J Immunol Methods; 1997 Jun; 205(1):73-9. PubMed ID: 9236917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Syndecan-1 expression--a novel prognostic marker in pancreatic cancer.
    Juuti A; Nordling S; Lundin J; Louhimo J; Haglund C
    Oncology; 2005; 68(2-3):97-106. PubMed ID: 15886501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syndecan-1 in B lymphoid malignancies.
    Sanderson RD; Børset M
    Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An antigenic study of human plasma cells in normal tissue and in myeloma: identification of a novel plasma cell associated antigen.
    Nathan PD; Walker L; Hardie D; Richardson P; Khan M; Johnson GD; Ling NR
    Clin Exp Immunol; 1986 Jul; 65(1):112-9. PubMed ID: 3024883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
    Kimlinger T; Witzig TE
    Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development.
    Zhan F; Tian E; Bumm K; Smith R; Barlogie B; Shaughnessy J
    Blood; 2003 Feb; 101(3):1128-40. PubMed ID: 12393520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
    Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
    Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors.
    Aref S; Goda T; El-Sherbiny M
    Hematology; 2003 Aug; 8(4):221-8. PubMed ID: 12911939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The expression, secretion and regulation of membrane-soluble syndecan-1 in human multiple myeloma cells].
    Li X; Lu Z; Klein B
    Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):572-6. PubMed ID: 11225246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow.
    Shapiro-Shelef M; Lin KI; Savitsky D; Liao J; Calame K
    J Exp Med; 2005 Dec; 202(11):1471-6. PubMed ID: 16314438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syndecan-1 signals independently of beta1 integrins during Raji cell spreading.
    Lebakken CS; McQuade KJ; Rapraeger AC
    Exp Cell Res; 2000 Sep; 259(2):315-25. PubMed ID: 10964499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells.
    Dhodapkar KM; Krasovsky J; Williamson B; Dhodapkar MV
    J Exp Med; 2002 Jan; 195(1):125-33. PubMed ID: 11781371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
    Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
    Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZB51: a monoclonal antibody reactive with human plasma cells.
    Webster R; Pulford K; Jones M; Micklem K; de Waele M; Mayne K; Tse A; Mason DY
    Br J Haematol; 1993 Aug; 84(4):602-7. PubMed ID: 8217816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and production of interleukin 10 in human myeloma cell lines.
    Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
    Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells.
    Lebakken CS; Rapraeger AC
    J Cell Biol; 1996 Mar; 132(6):1209-21. PubMed ID: 8601596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
    Hata H; Matsuzaki H; Matsuno F; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
    Clin Exp Immunol; 1994 May; 96(2):370-5. PubMed ID: 8187346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.